Case Report

Published on 10 Mar 2022

Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review

in Pharmacology of Anti-Cancer Drugs

Yuxin Lin
Wei Zhu
Bingchen Wu
Huiyin Lan

Frontiers in Oncology

doi 10.3389/fonc.2022.824308

3,000 views
7 citations

Original Research

Published on 09 Mar 2022

Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity

in Pharmacology of Anti-Cancer Drugs

Wongeun Lee
Dong Kwon Kim
Chun-Bong Synn
Hee Kyu Lee
Sungho Park
Dong-Sik Jung
Yewon Choi
Jae Hwan Kim
Youngseon Byeon
Young Seob Kim

Frontiers in Oncology

doi 10.3389/fonc.2022.821391

3,661 views
7 citations

Review

Published on 09 Mar 2022

Melanoma and Nanotechnology-Based Treatment

in Pharmacology of Anti-Cancer Drugs

Hong Zeng
Jia Li
Kai Hou
Yiping Wu
Hongbo Chen
Zeng Ning

Frontiers in Oncology

doi 10.3389/fonc.2022.858185

7,336 views
28 citations

Original Research

Published on 09 Mar 2022

Daemonorops draco Blume Induces Apoptosis Against Acute Myeloid Leukemia Cells via Regulation of the miR-216b/c-Jun

in Pharmacology of Anti-Cancer Drugs

Moon Nyeo Park
Hee Won Jeon
Md. Ataur Rahman
Se Sun Park
Se Yun Jeong
Ki Hyun Kim
Sung-Hoon Kim
Woojin Kim
Bonglee Kim

Frontiers in Oncology

doi 10.3389/fonc.2022.808174

3,276 views
5 citations

Original Research

Published on 08 Mar 2022

A Risk Scoring System Utilizing Machine Learning Methods for Hepatotoxicity Prediction One Year After the Initiation of Tyrosine Kinase Inhibitors

in Pharmacology of Anti-Cancer Drugs

Ji Min Han
Jeong Yee
Soyeon Cho
Min Kyoung Kim
Jin Young Moon
Dasom Jung
Jung Sun Kim
Hye Sun Gwak

Frontiers in Oncology

doi 10.3389/fonc.2022.790343

2,263 views
2 citations

Correction

Published on 07 Mar 2022

Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

in Pharmacology of Anti-Cancer Drugs

Xiu-Ying He
Yang Xu
Qing-Jie Xia
Xiao-Ming Zhao
Shan Li
Xiao-Qiong He
Ru-Rong Wang
Ting-Hua Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.872110

1,189 views

Case Report

Published on 04 Mar 2022

SDK1-ALK Fusion in a Lung Adenocarcinoma Patient With Excellent Response to ALK Inhibitor Treatment: A Case Report

in Pharmacology of Anti-Cancer Drugs

Lin Ma
Junjuan Xiao
Yaping Guan
Dongfang Wu
Tiantian Gu
Jun Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.860060

1,853 views
3 citations

Review

Published on 03 Mar 2022

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges

in Pharmacology of Anti-Cancer Drugs

Yun Beom Sang
Joo-Hang Kim
Chang-Gon Kim
Min Hee Hong
Hye Ryun Kim
Byoung Chul Cho
Sun Min Lim

Frontiers in Oncology

doi 10.3389/fonc.2022.811247

14,488 views
27 citations

Original Research

Published on 03 Mar 2022

α-Hederin Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Hippo-Yes-Associated Protein Signaling Pathway

in Pharmacology of Anti-Cancer Drugs

Tongqing Chen
Dongdong Sun
Qijuan Wang
Tingting Zhou
Jiani Tan
Changliang Xu
Haibo Cheng
Weixing Shen

Frontiers in Oncology

doi 10.3389/fonc.2022.839603

3,565 views
14 citations

Original Research

Published on 03 Mar 2022

Anesthesia With Propofol Sedation Reduces Locoregional Recurrence in Patients With Breast Cancer Receiving Total Mastectomy Compared With Non-Propofol Anesthesia

in Pharmacology of Anti-Cancer Drugs

Jiaqiang Zhang
Chia-Lun Chang
Chang-Yun Lu
Ho-Min Chen
Szu-Yuan Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.708632

2,764 views
2 citations

Original Research

Published on 02 Mar 2022

ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway

in Pharmacology of Anti-Cancer Drugs

Xiaochun Qin
Mingyue Liu
Chang Xu
Bo Xing
Xiangbo Xu
Yuting Wu
Huaiwei Ding
Qingchun Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.848952

2,781 views
5 citations

Systematic Review

Published on 01 Mar 2022

Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy

in Pharmacology of Anti-Cancer Drugs

Sajad Fakhri
Seyed Zachariah Moradi
Akram Yarmohammadi
Fatemeh Narimani
Carly E. Wallace
Anupam Bishayee

Frontiers in Oncology

doi 10.3389/fonc.2022.834072

6,265 views
27 citations

Correction

Published on 01 Mar 2022

Corrigendum: Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis

in Pharmacology of Anti-Cancer Drugs

Bochao Geng
Yuanzhang Zhu
Yingying Yuan
Jingyi Bai
Zhizhi Dou
Aihua Sui
Wenjuan Luo

Frontiers in Oncology

doi 10.3389/fonc.2022.870805

1,227 views
1 citation

Review

Published on 01 Mar 2022

Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment

in Pharmacology of Anti-Cancer Drugs

Paola Allavena
Cristina Belgiovine
Elisabeth Digifico
Roberta Frapolli
Maurizio D’Incalci

Frontiers in Oncology

doi 10.3389/fonc.2022.851790

4,774 views
16 citations

Case Report

Published on 25 Feb 2022

Case Report: Patient With Lung Adenocarcinoma With ALK-HLA-DRB1 Rearrangement Shows Impressive Progression-Free Survival After Sequential Crizotinib and Ceritinib Treatment

in Pharmacology of Anti-Cancer Drugs

Peng Gao
Kangning Tang
Yuqiu Hao
Wei Li
Xuejiao Lv
Dapeng Li
Yuxi Jia

Frontiers in Oncology

doi 10.3389/fonc.2022.762338

1,856 views
2 citations

Editorial

Published on 24 Feb 2022

Editorial: Anticancer Potential of Artemisia annua

in Pharmacology of Anti-Cancer Drugs

Jill M. Kolesar
Peter H. Seeberger

Frontiers in Oncology

doi 10.3389/fonc.2022.853406

5,735 views
2 citations

Navigation group

Articles

Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review

Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity

Melanoma and Nanotechnology-Based Treatment

Daemonorops draco Blume Induces Apoptosis Against Acute Myeloid Leukemia Cells via Regulation of the miR-216b/c-Jun

A Risk Scoring System Utilizing Machine Learning Methods for Hepatotoxicity Prediction One Year After the Initiation of Tyrosine Kinase Inhibitors

Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

SDK1-ALK Fusion in a Lung Adenocarcinoma Patient With Excellent Response to ALK Inhibitor Treatment: A Case Report

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges

α-Hederin Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Hippo-Yes-Associated Protein Signaling Pathway

Anesthesia With Propofol Sedation Reduces Locoregional Recurrence in Patients With Breast Cancer Receiving Total Mastectomy Compared With Non-Propofol Anesthesia

ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway

Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy

Corrigendum: Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis

Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment

Case Report: Patient With Lung Adenocarcinoma With ALK-HLA-DRB1 Rearrangement Shows Impressive Progression-Free Survival After Sequential Crizotinib and Ceritinib Treatment

Editorial: Anticancer Potential of Artemisia annua